Skip to content
10-Q

Quarterly Report

VERTEX PHARMACEUTICALS INC / MA VRTX

0000875320-25-000216

← back to feed
Filed
Aug 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 31, 2025 256.39M sh
Shares Diluted Q2 2025 · Jun 30, 2025 258.9M sh
Shares Diluted Q2 2025 · Jun 30, 2025 259.2M sh
Shares Diluted Q2 2025 · Jun 30, 2024 258.1M sh
Shares Diluted Q2 2025 · Jun 30, 2024 258.1M sh
Stock Repurchased Q2 2025 · Jun 30, 2025 $817.9M
Stock Repurchased Q2 2025 · Jun 30, 2024 $451.5M
Capex Q2 2025 · Jun 30, 2025 $186.4M
Capex Q2 2025 · Jun 30, 2024 $137.4M
Operating Cash Flow Q2 2025 · Jun 30, 2025 $1.89B
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$2.45B
Cash And Equivalents Q2 2025 · Jun 30, 2025 $4.97B
Cash And Equivalents Q2 2025 · Dec 31, 2024 $4.57B
Cash And Equivalents Q2 2025 · Jun 30, 2024 $4.58B
Cash And Equivalents Q2 2025 · Dec 31, 2023 $10.37B
Stockholders Equity Q2 2025 · Jun 30, 2025 $17.18B
Stockholders Equity Q2 2025 · Mar 31, 2025 $16.5B
Stockholders Equity Q2 2025 · Dec 31, 2024 $16.41B
Stockholders Equity Q2 2025 · Jun 30, 2024 $14.77B
Stockholders Equity Q2 2025 · Mar 31, 2024 $18.55B
Stockholders Equity Q2 2025 · Dec 31, 2023 $17.58B
Current Liabilities Q2 2025 · Jun 30, 2025 $4.14B
Current Liabilities Q2 2025 · Dec 31, 2024 $3.56B
Total Liabilities Q2 2025 · Jun 30, 2025 $6.86B
Total Liabilities Q2 2025 · Dec 31, 2024 $6.12B
Current Assets Q2 2025 · Jun 30, 2025 $10.43B
Current Assets Q2 2025 · Dec 31, 2024 $9.6B
Total Assets Q2 2025 · Jun 30, 2025 $24.04B
Total Assets Q2 2025 · Dec 31, 2024 $22.53B
Eps Diluted Q2 2025 · Jun 30, 2025 $3.99
Eps Diluted Q2 2025 · Jun 30, 2025 $6.48
Eps Diluted Q2 2025 · Jun 30, 2024 −$13.92
Eps Diluted Q2 2025 · Jun 30, 2024 −$9.66
Eps Basic Q2 2025 · Jun 30, 2025 $4.02
Eps Basic Q2 2025 · Jun 30, 2025 $6.54
Eps Basic Q2 2025 · Jun 30, 2024 −$13.92
Eps Basic Q2 2025 · Jun 30, 2024 −$9.66
Sga Expense Q2 2025 · Jun 30, 2025 $424.6M
Sga Expense Q2 2025 · Jun 30, 2025 $821M
Sga Expense Q2 2025 · Jun 30, 2024 $372.2M
Sga Expense Q2 2025 · Jun 30, 2024 $714.9M
Net Income Q2 2025 · Jun 30, 2025 $1.03B
Net Income Q2 2025 · Jun 30, 2025 $1.68B
Net Income Q2 2025 · Jun 30, 2024 −$3.59B
Net Income Q2 2025 · Jun 30, 2024 −$2.49B
Operating Income Q2 2025 · Jun 30, 2025 $1.15B
Operating Income Q2 2025 · Jun 30, 2025 $1.78B
Operating Income Q2 2025 · Jun 30, 2024 −$3.51B
Operating Income Q2 2025 · Jun 30, 2024 −$2.38B
Cost Of Revenue Q2 2025 · Jun 30, 2025 $407.5M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $770.5M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $371.9M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $714.5M
Revenue Q2 2025 · Jun 30, 2025 $2.96B
Revenue Q2 2025 · Jun 30, 2025 $5.73B
Revenue Q2 2025 · Jun 30, 2024 $2.65B
Revenue Q2 2025 · Jun 30, 2024 $5.34B